UPDATE 1-European shares rise; AstraZeneca drops after halting vaccine trials

  • 11 months ago
  • news
  • 1

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

* AstraZeneca biggest drag on STOXX 600

* Travel & leisure stocks underperform among sector indexes

* Expectations for STOXX 600 earnings worsen for Q3

* ECB policy meeting eyed for Thursday (Adds comments, background; updates prices)

By Shreyashi Sanyal

Sept 9 (Reuters) – European shares bounced back a bit on Wednesday after steep declines in the previous session, although sentiment remained fragile after AstraZeneca suspended global trials of its COVID-19 vaccine.

AstraZeneca Plc shares fell 0.5% as it also paused large late-stage trials of its experimental vaccine due to an unexplained illness in a study participant. halt in the AstraZeneca vaccine trial comes as a blow to global economic confidence, noted global strategist, Michael Every at Rabobank.

“Halting trials of the ‘Oxford’ virus vaccine after a test subject suffered an unexplained serious illness is standard procedure, but is going to generate concern.”

The pan-European STOXX 600 index rose 0.8%, with sub-indexes of sectors hit most by the pandemic lagging. Travel and leisure stocks fell 1.5%, while autos dropped 0.6%.

Defensive plays such as utilities , telecoms and healthcare on the other hand, rose more than 1%.

British airline easyJet tumbled 4.6%, the most on the sub-index and a day after it reduced its flying schedule as frequent changes in government restrictions on travel hit demand.

Airlines Ryanair , IAG and cruise operator Carnival (NYSE:) fell between 2.6% and 4%.

Moves in the STOXX 600 index have remained stuck in a tight range since June. Investors are bracing for the European Central Bank’s (ECB) policy meeting on Thursday, which could act as the next catalyst.

Analysts are not expecting any surprises with regards to changes in rate policy, focussing more on the central bank’s inflation outlook and commentary on the euro’s recent strength.

“Key focus would be on Christine Lagarde’s press conference and whether she echoes her ECB colleagues’ concerns of a rising euro and how that could weigh on price pressures, while at the same time a stronger euro may result in the EU’s exports becoming less competitive,” said analysts at Maybank.

Investors were closely following developments around Britain’s plan for a life outside the European Union as the UK published legislation, a government minister acknowledged would break international law in a “limited way” and which could sour trade talks. for third quarter STOXX 600 earnings have worsened as shown by the latest data from Refinitiv. Profits are expected to fall 39.2% for the 600 companies listed on the pan-European index, against 37.9% a week earlier.

Source by [author_name]

Compare listings

%d bloggers like this: